Free Trial
NASDAQ:EDAP

EDAP TMS Q2 2025 Earnings Report

EDAP TMS logo
$1.25 -0.05 (-3.49%)
Closing price 08/8/2025 03:59 PM Eastern
Extended Trading
$1.24 0.00 (-0.32%)
As of 08/8/2025 04:01 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

EDAP TMS EPS Results

Actual EPS
N/A
Consensus EPS
-$0.18
Beat/Miss
N/A
One Year Ago EPS
N/A

EDAP TMS Revenue Results

Actual Revenue
N/A
Expected Revenue
$16.60 million
Beat/Miss
N/A
YoY Revenue Growth
N/A

EDAP TMS Announcement Details

Quarter
Q2 2025
Time
Before Market Opens
Conference Call Date
Thursday, August 28, 2025
Conference Call Time
8:30AM ET

Conference Call Resources

EDAP TMS Earnings Headlines

Alex’s “Next Magnificent Seven” stocks
The original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Magnificent Seven—seven stocks he believes could deliver similar gains in under six years. His full breakdown is now live.
See More EDAP TMS Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like EDAP TMS? Sign up for Earnings360's daily newsletter to receive timely earnings updates on EDAP TMS and other key companies, straight to your email.

About EDAP TMS

EDAP TMS (NASDAQ:EDAP) SA is a holding company, which, through its subsidiary, engages in the development, production, and marketing of minimally invasive medical devices for urological diseases. It operates through the High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) segments. The HIFU segment develops, manufactures, and markets devices for the minimally invasive ablation of certain types of localized tumors using HIFU technology. The UDS segment focuses on the development, marketing, manufacturing, and servicing of medical devices for the minimally invasive diagnosis or treatment of urological disorders, mainly urinary stones, and other clinical indications. The company was founded on December 3, 1979 and is headquartered in Vaulx-en-Velin, France.

View EDAP TMS Profile

More Earnings Resources from MarketBeat